Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/11
End: 11/30/12
Due: 11/30/13
Phase: N/A
Priority: Normal
Start: 08/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 07/31/12
Due: 07/31/13
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's Disease | NCT01316601 | Gerhard Rogler | user2@example.com | None | 2011-01-31 | 2012-11-30 | 2013-11-30 | - | - | 2025-07-14 |
| The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients | NCT01012570 | Gerhard Rogler | user2@example.com | None | 2009-08-31 | - | - | - | - | 2025-07-14 |
| Study About the Effect of Doxycycline and Acetylcystein in the Treatment of CD-associated Fistulae | NCT01012726 | Gerhard Rogler | user2@example.com | None | 2009-11-30 | 2012-07-31 | 2013-07-31 | - | - | 2025-07-14 |